Academic Journal
Q1Cancer Communications
About Cancer Communications
Cancer Communications is a scholarly journal published by John Wiley & Sons Inc.. SCImago 2025 lists it in Q1, with an SJR of 7.986 and H-index of 108.
Coverage: 2017-2026. Research categories: Cancer Research (Q1); Oncology (Q1).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
GULP1 Fuels Resistance to PD-1 Blockade through Lipid-Mediated Metabolic Reprogramming of Tumor-Associated Macrophages in Gastric Cancer
Zihao Zhang, Wenxin Xu, Kuan Yu, Anran Bao et al.
2026-08-31 · DOI: 10.34133/cancomm.0054Stress Biology in Cancer: Neuroendocrine–Immune Mechanisms Linking Tumor Progression to Translational Interventions
Wancheng Liu, Chi Ma, Yukang Ma, Xiangling Xing et al.
2026-08-26 · DOI: 10.34133/cancomm.0053The Five-Decade Journey of Small Cell Lung Cancer
sheng hu, Runzhi Chen, Chang Xue, Yi Zhong et al.
2026-08-25 · DOI: 10.34133/cancomm.0052Spatiotemporal Analysis of Molecular Continuity in Pathogenesis of Squamous-cell Carcinoma: from Normal Epitheliumto Precancerous Lesions and Carcinoma
Lan Lan, Xinyu Wang, Xiaoqi Jiang, Xiangyi Lin et al.
2026-08-20 · DOI: 10.34133/cancomm.0051Tumor HMGB1-induced neutrophil senescence drives HCC via NETs-mediated CD8⁺ T cell dysfunction
Yaqian Duan, Shan Yu, Xuanyi Wang, Rong Wu et al.
2026-08-19 · DOI: 10.34133/cancomm.0050NBR1-mediated autophagic degradation of YTHDF1 curtails FDX1 translation to drive concurrent multikinase inhibitor resistance and cuproptosis tolerance
Weikai Wang, Xin Jiang, Xiaona Chen, Kaiyu Liang et al.
2026-08-12 · DOI: 10.34133/cancomm.0048The PROM1 + SMAD5 + tumor-initiating subpopulation shapes pre-metastatic niches through spatial multi-omics landscapes in HER2-positive breast cancer
Huijing Yin, Wei Wang, Jing Ge, Guangjian Fan et al.
2026-08-10 · DOI: 10.34133/cancomm.0046Beyond Structure: The Dynamic Role of the Extracellular Matrix Components in Immune Evasion
Mohsin Maqbool, Anju Surendranath, Sadaf K. Baba, Tooba Jawwad et al.
2026-08-05 · DOI: 10.34133/cancomm.0045Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand–Ir(III) Complex Conjugates
Valentina Pagliara, Giulia Assoni, Giovanna Polcaro, Alberto Bossi et al.
2026-01-01 · DOI: 10.34133/cancomm.0029Excess Weight May Account for More Than 10% of All Cancers: The Underestimated Impact of the Obesity Epidemic
Luna Kiran Adhikari, Fatemeh Safizadeh, Marko Mandic, Hermann Brenner et al.
2026-01-01 · DOI: 10.34133/cancomm.0040First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression
Ru Jia, Yan-Rong Wang, Fang-Fang Liu, Yue Ma et al.
2026-01-01 · DOI: 10.34133/cancomm.0024Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma
Yun Seong Jeong, Ji-Hyun Shin, Soo Mi Kim, Bo Hwa Sohn et al.
2026-01-01 · DOI: 10.34133/cancomm.0020Ectopic CD11c Drives SMAD3-Mediated Aberrant Antigen Presentation and Epithelial–Mesenchymal Transition in Esophageal Squamous Cell Carcinoma
Han Liao, Xuan Zhao, Liping Chen, Qingyi Liu et al.
2026-01-01 · DOI: 10.34133/cancomm.0014The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer Immunotherapy
Yingying Lv, Tingfei Duan, Jinling Song, Shutong Liu et al.
2026-01 · DOI: 10.34133/cancomm.0002Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II Study
Haifeng Li, Meiting Chen, Riqing Huang, Qixiang Rong et al.
2026-01-01 · DOI: 10.34133/cancomm.0025TIMELESS Promotes LUAD Growth via Suppressing Transferrin-Mediated Ferroptosis and Reprograms the Tumor Microenvironment against Anti-PD-1 Immunotherapy
Chenchen Hu, Feiming Hu, Changjian Shao, Yuanli He et al.
2026-01 · DOI: 10.34133/cancomm.0009Treatment of Metastatic Cancer by Conferring Immunogenicity to the Apoptotic Bodies of the Primary Tumor
So-Jung Kim, Hae-Bin Park, Eun-Koung An, Dayoung Ryu et al.
2026-01 · DOI: 10.34133/cancomm.0001Tumor Microenvironment Onmyoji: Cytokines with Dual Protumor and Antitumor Roles
Yaxuan Wang, Anqi Lin, Zaoqu Liu, Quan Cheng et al.
2026-01 · DOI: 10.34133/cancomm.0008EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity
Yunfei Zhu, Xuetao Cao
2026-01-01 · DOI: 10.34133/cancomm.0027Effectiveness of Lung Cancer Screening by Sex and Tumor Histology: Extended, Pooled Analysis of the ITALUNG and LUSI Trials, with Comparison to Findings in the NLST
Rudolf Kaaks, Francisco Omar Cortés-Ibáñez, Stefan Delorme, Erna Motsch et al.
2026-01-01 · DOI: 10.34133/cancomm.0011Reviews
Community Reviews
Version History
September 8, 2026 at 7:40 am
September 8, 2026